Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCORPIO-V is the biological sciences division of HNu Photonics focused on automated microfluidic and live-cell imaging platforms for biological research, especially in microgravity environments. Its flagship Bio-Chip Space-Lab (BCSL) and Mobile SpaceLab enable long-duration cell culture, microscopy, reagent delivery, and remote experiment control aboard the International Space Station. The group supports academic and industry users with customized experimental design for 2-D and 3-D tissue culture, organoids, and organ-on-a-chip studies. SCORPIO-V appears to be a platform and instrumentation business rather than a traditional therapeutics developer, with applications spanning drug discovery, cancer biology, stem cell research, assisted reproductive technologies, and space biology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCORPIO-V.